Medinex Ltd. (SG:OTX)
SGX:OTX
Want to see SG:OTX full AI Analyst Report?
Top Page
Medinex Ltd.
(SGX:OTX)
Select Model
Select Model
Rating:77Outperform
Price Target:
S$0.26
â–²(8.75% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by strong financial performance (high margins, low leverage, and solid cash conversion) and supportive valuation (low P/E and high dividend yield). This is tempered by mixed/neutral technical signals, including slightly negative MACD and prices sitting near moving averages.
Positive Factors
High Profitability / Margins
Sustained gross (~77%) and net (~22%) margins materially bolster durable earnings power and internal funding capacity. High margins provide structural cushion against reimbursement or cost shocks, support reinvestment and dividends, and improve resilience across economic cycles over the next several quarters.
Negative Factors
Revenue Growth Volatility
Irregular top-line trends, including prior declines and a 2025 rebound, weaken predictability of future sales and cash flow. This volatility complicates capacity planning and raises the risk that recent margin and cash improvements are cyclical rather than structural, challenging durable growth planning.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability / Margins
Sustained gross (~77%) and net (~22%) margins materially bolster durable earnings power and internal funding capacity. High margins provide structural cushion against reimbursement or cost shocks, support reinvestment and dividends, and improve resilience across economic cycles over the next several quarters.
Read all positive factors
Medinex Ltd. (OTX) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$30.95M
Dividend Yield7.3%
Average Volume (3M)102.58K
Price to Earnings (P/E)8.6
Beta (1Y)<0.01
Revenue Growth-2.08%
EPS Growth129.31%
CountrySG
Employees73
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.02
Shares Outstanding134,543,840
10 Day Avg. Volume45,910
30 Day Avg. Volume102,580
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)1.57
Price to Sales (P/S)2.05
P/FCF Ratio7.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medinex Ltd. Business Overview & Revenue Model
Company Description
Medinex Limited, an investment holding company, provides professional support services to medical clinics in Singapore. It operates through four segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Se...
Medinex Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
83
Very Positive
Cash Flow
86
Very Positive
| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.81M | 12.58M | 12.97M | 11.99M | 10.79M |
| Gross Profit | 9.93M | 9.68M | 9.48M | 8.57M | 3.31M |
| EBITDA | 3.58M | 1.79M | 2.88M | 4.00M | 1.69M |
| Net Income | 2.83M | 1.03M | 1.70M | 2.81M | 3.49M |
Balance Sheet | |||||
| Total Assets | 20.69M | 20.50M | 22.59M | 22.98M | 23.43M |
| Cash, Cash Equivalents and Short-Term Investments | 5.56M | 5.17M | 4.15M | 6.34M | 6.73M |
| Total Debt | 1.67M | 2.08M | 2.34M | 3.10M | 3.95M |
| Total Liabilities | 3.96M | 4.34M | 4.81M | 5.51M | 6.50M |
| Stockholders Equity | 16.72M | 16.12M | 17.57M | 17.25M | 16.66M |
Cash Flow | |||||
| Free Cash Flow | 3.33M | 2.67M | 2.83M | 2.63M | 2.96M |
| Operating Cash Flow | 3.35M | 2.70M | 3.03M | 2.86M | 3.04M |
| Investing Cash Flow | 243.45K | 1.66M | -2.19M | -16.91K | -2.61M |
| Financing Cash Flow | -3.20M | -3.33M | -3.02M | -3.16M | 748.53K |
Medinex Ltd. Technical Analysis
Positive
0.24
Price Trends
0.23
Positive
0.23
Positive
0.22
Positive
Market Momentum
<0.01
Negative
61.72
Neutral
60.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:OTX, the sentiment is Positive. The current price of 0.24 is above the 20-day moving average (MA) of 0.23, above the 50-day MA of 0.23, and above the 200-day MA of 0.22, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 61.72 is Neutral, neither overbought nor oversold. The STOCH value of 60.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:OTX.
Medinex Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
SG:OTX
Medinex Ltd.
0.23
0.04
21.05%
SG:1J5
Hyphens Pharma International Ltd.
0.35
0.08
29.63%
SG:40T
ISEC Healthcare Ltd
0.33
-0.02
-5.71%
SG:505
Asiamedic Limited
0.02
0.01
120.00%
SG:546
Medtecs International Corporation Ltd.
0.12
<0.01
5.31%
SG:MIJ
Alliance Healthcare Group Ltd.
0.15
0.05
52.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.